KCNJ10 and Alzheimer disease: They found that reactive astrocytes expressed an intense immunoreactivity for Kir4.1 in active demyelinating lesions of MS, active lesion edges of NMO, ischemic lesion edges of cerebral infarction, and neurodegenerative lesions of Alzheimer’s disease.